159 related articles for article (PubMed ID: 22458412)
1. Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts.
Dai Y; Tang Y; He F; Zhang Y; Cheng A; Gan R; Wu Y
Virol J; 2012 Mar; 9():77. PubMed ID: 22458412
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis of differentially expressed genes and identification of key genes in EBV-transformed lymphoblasts.
Tang Y; Zhong Y; Fu T; Zhang Y; Cheng A; Dai Y; Qu J; Gan R
Biomed Pharmacother; 2019 Aug; 116():108984. PubMed ID: 31129512
[TBL] [Abstract][Full Text] [Related]
3. Screening and functional analysis of differentially expressed genes in chronic glomerulonephritis by whole genome microarray.
Gao JR; Qin XJ; Jiang H; Wang T; Song JM; Xu SZ
Gene; 2016 Sep; 589(1):72-80. PubMed ID: 27222482
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays.
Islam TC; Lindvall J; Wennborg A; Brandén LJ; Rabbani H; Smith CI
Eur J Immunol; 2002 Apr; 32(4):982-93. PubMed ID: 11920564
[TBL] [Abstract][Full Text] [Related]
5. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
6. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
[TBL] [Abstract][Full Text] [Related]
8. Expression of latent membrane proteins in Epstein‑Barr virus-transformed lymphocytes in vitro.
Tang Y; Luo C; Cheng A; Lu S; Xu J; Fu T; Gan R
Mol Med Rep; 2014 Aug; 10(2):1117-21. PubMed ID: 24919846
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
Wilson AD; Redchenko I; Williams NA; Morgan AJ
Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
Becker Y; Tabor E; Asher Y
Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
[TBL] [Abstract][Full Text] [Related]
12. Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs).
Wroblewski JM; Copple A; Batson LP; Landers CD; Yannelli JR
J Immunol Methods; 2002 Jun; 264(1-2):19-28. PubMed ID: 12191505
[TBL] [Abstract][Full Text] [Related]
13. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits.
Lee JE; Hong EJ; Nam HY; Kim JW; Han BG; Jeon JP
Cell Prolif; 2011 Feb; 44(1):59-66. PubMed ID: 21199010
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.
Hertle ML; Popp C; Petermann S; Maier S; Kremmer E; Lang R; Mages J; Kempkes B
PLoS Pathog; 2009 Jul; 5(7):e1000506. PubMed ID: 19578441
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation.
Jeon JP; Kim JW; Park B; Nam HY; Shim SM; Lee MH; Han BG
Acta Virol; 2008; 52(3):151-9. PubMed ID: 18999889
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.
Vrzalikova K; Vockerodt M; Leonard S; Bell A; Wei W; Schrader A; Wright KL; Kube D; Rowe M; Woodman CB; Murray PG
Blood; 2011 Jun; 117(22):5907-17. PubMed ID: 21411757
[TBL] [Abstract][Full Text] [Related]
19. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
Wilson AD; Morgan AJ
J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
